![](https://www.texasretina.com/wp-content/uploads/2024/07/Abbey-ASRS-2024.png)
Posted On July 24, 2024 /
By Debbie Muse / Posted in Blog
Ashkan M. Abbey, MD, Presented Real-world Outcomes of Fluocinolone Acetonide Intravitreal Implant for Non-infectious Uveitis at ASRS 2024 Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented “36-month Optical Coherence Tomography Outcomes from CALM: A Registry Evaluating Treatment of Chronic Non-infectious Uveitis with the 0.18 mg Fluocinolone Acetonide Intravitreal Implant” at the
read more![](https://www.texasretina.com/wp-content/uploads/2021/03/Screen-Shot-2021-03-26-at-1.45.32-PM.png)
Posted On March 26, 2021 /
By Debbie Muse / Posted in Blog
Dr. Wang’s Research Published in British Journal of Ophthalmology
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Extension Study of the Safety and Efficacy of CLS-TA for Treatment of Macular Edema Associated with Non-infectious Uveitis (MAGNOLIA)” in the
read more![](https://www.texasretina.com/wp-content/uploads/2021/01/Screen-Shot-2021-01-21-at-5.53.05-PM.png)
Posted On January 26, 2021 /
By Debbie Muse / Posted in Uncategorized
Dr. Wang Published Article on Long-term Inflammation Control and Uveitis in Retina Today
Texas Retina Associates’ Robert C. Wang, MD, shared three case studies in an article titled “Long-term Inflammation Control Benefits All Types of Uveitis” published in the November/December 2020 issue of the medical
read more